Immuron (ASX:IMC) Trading Down 10%

Share on StockTwits

Immuron Limited (ASX:IMC)’s share price was down 10% during mid-day trading on Wednesday . The stock traded as low as A$0.14 ($0.10) and last traded at A$0.14 ($0.10), approximately 571,942 shares were traded during trading. The stock had previously closed at A$0.15 ($0.11).

The business has a fifty day moving average of A$0.13. The stock has a market cap of $23.87 million and a PE ratio of -4.22.

About Immuron (ASX:IMC)

Immuron Limited, a biopharmaceutical company, focuses on the research and development of immunomodulatory polyclonal antibodies for the treatment and prevention of various diseases through its oral immunoglobulins platform in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments.

Read More: How does equity income fit into an investing strategy?

Receive News & Ratings for Immuron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immuron and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.